Effect of Ginseng in Type 2 Diabetes

Clinical Trial ID NCT02923453

PubWeight™ 0.00‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02923453

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972 95.79
2 Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002 16.23
3 Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008 12.41
4 Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009 12.38
5 Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015 12.05
6 Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA 2005 9.61
7 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2013 5.02
8 Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA 2003 4.38
9 Adiponectin: more than just another fat cell hormone? Diabetes Care 2003 3.30
10 Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes. Diabetes Care 2007 2.92
11 Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA 2014 2.59
12 Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann Intern Med 2015 2.31
13 Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on C-reactive protein: a meta-analysis. J Am Coll Cardiol 2007 2.16
14 Effects of dietary fibre on subjective appetite, energy intake and body weight: a systematic review of randomized controlled trials. Obes Rev 2011 1.60
15 Inulin-type fructans: functional food ingredients. J Nutr 2007 1.53
16 Weight science: evaluating the evidence for a paradigm shift. Nutr J 2011 1.42
17 Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity-a review. Nutrients 2010 1.28
18 Dietary fiber for the treatment of type 2 diabetes mellitus: a meta-analysis. J Am Board Fam Med 2012 1.23
19 Viscous fibers, health claims, and strategies to reduce cardiovascular disease risk. Am J Clin Nutr 2000 1.14
20 Topiramate in the treatment of obese subjects with drug-naive type 2 diabetes. Diabetes Obes Metab 2007 1.14
21 Dietary treatment and long-term weight loss and maintenance in type 2 diabetes. Obes Res 2001 1.07
22 Weight management in type 2 diabetes: current and emerging approaches to treatment. Diabetes Care 2015 0.99
23 Physiological evidence for the involvement of peptide YY in the regulation of energy homeostasis in humans. Obesity (Silver Spring) 2006 0.97
24 Dietary levels of chia: influence on yolk cholesterol, lipid content and fatty acid composition for two strains of hens. Poult Sci 2000 0.95
25 Circulating levels of active ghrelin is associated with abdominal adiposity, hyperinsulinemia and insulin resistance in patients with type 2 diabetes mellitus. Eur J Endocrinol 2004 0.95
26 Chia seed does not promote weight loss or alter disease risk factors in overweight adults. Nutr Res 2009 0.89
27 Fiber facts: benefits and recommendations for individuals with type 2 diabetes. Curr Diab Rep 2009 0.88
28 Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial. Diabetes Care 2007 0.87
29 Reduction in postprandial glucose excursion and prolongation of satiety: possible explanation of the long-term effects of whole grain Salba (Salvia Hispanica L.). Eur J Clin Nutr 2010 0.86
30 Dietary antioxidant capacity and concentration of adiponectin in apparently healthy adults: the ATTICA study. Eur J Clin Nutr 2009 0.83
31 To JUPITER and beyond: statins, inflammation, and primary prevention. Crit Care 2010 0.82
32 Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome. Asia Pac J Clin Nutr 2012 0.82
33 Dietary alpha-linolenic acid increases the n-3 PUFA content of sow's milk and the tissues of the suckling piglet. Lipids 2003 0.81
34 The seed's protein and oil content, fatty acid composition, and growing cycle length of a single genotype of chia (Salvia hispanica L.) as affected by environmental factors. J Oleo Sci 2009 0.79
35 Chia seed supplementation and disease risk factors in overweight women: a metabolomics investigation. J Altern Complement Med 2012 0.79
36 Chia (Salvia hispanica): A Review of Native Mexican Seed and its Nutritional and Functional Properties. Adv Food Nutr Res 2015 0.76
37 Effect of dietary fiber on circulating C-reactive protein in overweight and obese adults: a meta-analysis of randomized controlled trials. Int J Food Sci Nutr 2015 0.76
Next 100